A Study to Evaluate the Efficacy and Safety of Abiprubart in Participants With Sjögren's Disease
Clinical trial NCT06531395 · TERMINATED
Trial details
- NCT number
- NCT06531395
- Sponsor
- Kiniksa Pharmaceuticals International, plc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-17
- Primary completion
- 2025-03-06
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.